Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13121333 | 0.94 | SLC5A2 (0.37) | SLC5A2MMP12 | |
| SCHEMBL13121329 | 0.84 | CYP3A4 (0.34) | SLC5A2 | |
| SCHEMBL3441881 | 0.84 | CYP3A4 (0.34) | SLC5A2 | |
| SCHEMBL3442029 | 0.83 | TSHR (0.32) | — | |
| SCHEMBL3441879 | 0.82 | CYP2C19 (0.31) | MMP12 | |
| SCHEMBL13415299 | 0.78 | SLC5A2 (0.43) | SLC5A2 | |
| SCHEMBL468525 | 0.78 | SLC5A2 (0.43) | SLC5A2 | |
| SCHEMBL4633309 | 0.78 | SLC5A2 (0.53) | SLC5A2 | |
| SCHEMBL7155412 | 0.78 | SLC5A2 (0.53) | SLC5A2 | |
| SCHEMBL9809794 | 0.73 | SLC5A2 (0.37) | SLC5A2MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1554299-B1 | NOVEL PENTOSE DERIVATIVES AS ANTI-HYPERGLYCEMIC DRUGS | YISSUM RES DEV CO (IL) | 2013-01-30 | — | — | EP | claimed |
| EP-1554299-A2 | NOVEL PENTOSE DERIVATIVES AS ANTI-HYPERGLYCEMIC DRUGS | Yissum Research Development Company of the Hebrew University of Jerusalem (IL) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004034960-A2 | NOVEL PENTOSE DERIVATIVES AS ANTI-HYPERGLYCEMIC DRUGS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2004-04-29 | — | — | WO | disclosed |